Frontlight ResearchEarly access
Trial site
Liaoning Provincial Cancer Hospital
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 22 trials
- Phase 31 trial
- Status
- Not yet recruiting2 trials
- Recruiting1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Jingdong Zhang1 trial
- Tianjin Medical University Cancer Institute and Hospital1 trial
Running trials
Not yet recruiting
Recruiting
SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy Failure
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Metastatic breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026